New York Thoroughbred Horsemen’s Association Gift helps launch Cornell Equine

The New York Thoroughbred Horsemen’s Association (NYTHA) has made a generous contribution of $25,000 to support the development of Cornell Equine. This cross-campus program, rooted in Cornell University’s rich legacy of scientific research clinical care and education, and based at the Cornell University College of Veterinary Medicine (CVM), aims to advance equine health and education through enhanced collaboration amongst interdisciplinary teams.

“We are so grateful for the support of NYTHA in helping us bring Cornell Equine to fruition,” says Dr. Mandi de Mestre, professor of equine medicine with the Baker Institute for Animal Health and Department of Biomedical Sciences at CVM. “This gift will support us to take the first steps in leveraging the exceptional breadth of skills of Cornell faculty to tackle novel research questions in equine health and safety and build leadership capacity for the future. A coordinated equine program will also bolster the University’s efforts to recruit and retain the best veterinary students into equine practice through enhanced and coordinated access to educational opportunities, faculty support and industry.”

“The College of Veterinary Medicine has a long-standing history of driving research and clinical results that have had lasting impact on the Thoroughbred industry and equine health and care,” said Tina Marie Bond, president of the NYTHA. “We are pleased to be able to support the college as it builds upon this legacy.”

This gift will be instrumental in Cornell Equine’s first phase of development, in which a new, two-way communication platform will be launched to invite horse owners, trainers and veterinarians to discuss their most pressing issues, ultimately guiding future research and education programs. This platform will enhance dissemination of research results to deliver benefits nationally to equine management and clinical services. This initial phase of the initiative is underway, and it is anticipated to be available to the equine field at large by the summer of 2025.